The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study

<b>Background:</b> Medication-related problems (MRPs) are common among home-care patients urgently needing improvement. Due to limited resources, patients with the greatest risk of MRPs should be prioritised for interventions. <b>Objectives:</b> We sought to develop a collabo...

Full description

Saved in:
Bibliographic Details
Main Authors: Carla Meyer-Massetti, Stefanie Lettieri-Amstutz, Daniela Rölli, Christoph R. Meier
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Nursing Reports
Subjects:
Online Access:https://www.mdpi.com/2039-4403/15/5/158
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849327218654707712
author Carla Meyer-Massetti
Stefanie Lettieri-Amstutz
Daniela Rölli
Christoph R. Meier
author_facet Carla Meyer-Massetti
Stefanie Lettieri-Amstutz
Daniela Rölli
Christoph R. Meier
author_sort Carla Meyer-Massetti
collection DOAJ
description <b>Background:</b> Medication-related problems (MRPs) are common among home-care patients urgently needing improvement. Due to limited resources, patients with the greatest risk of MRPs should be prioritised for interventions. <b>Objectives:</b> We sought to develop a collaborative assessment tool for nurses and pharmacists to identify home-care patients at high risk of developing MRPs. <b>Methods:</b> Using Pubmed<sup>®</sup> for a first scoping literature review, we sought existing tools identifying patients at risk of MRPs or prioritising patients for clinical pharmacy services. Extracted items were prioritised in a first interprofessional Delphi round. Results from the first Delphi round were complemented by individual risk factors identified in a second scoping literature review and again submitted to the expert panel in a second Delphi round. Each item was rated for its relevance to identify home-care patients at risk of MRPs. The highest scoring factors were combined into an interprofessional assessment tool. <b>Results:</b> Literature review one yielded 19 risk tools and six lists containing potentially inappropriate medications. The 78 resulting risk factors were submitted to experts (five pharmacists, five physicians, five nurses) in Delphi round one. Since the identified tools did not fit the scope (interprofessional assessment in home care) entirely, the results of Delphi round one were complemented with individual risk factors identified in a second literature review, leading to 82 potential risk factors for Delphi round two. Experts decided on a 15-item tool for future pilot testing—the doMESTIC RISK tool. It incorporated diverse factors potentially influencing medication safety: demographic information, social context, diagnosis, specific medication and health care resources use. <b>Conclusions:</b> With expert feedback from a Delphi process, we developed a 15-item tool to help nurses and pharmacists jointly identify home-care patients at a high risk of MRPs. Validation of the doMESTIC RISK tool will be imperative to verify its value in clinical practice.
format Article
id doaj-art-22ceb6c6d27e403ab7e88ab1a7618ffe
institution Kabale University
issn 2039-439X
2039-4403
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Nursing Reports
spelling doaj-art-22ceb6c6d27e403ab7e88ab1a7618ffe2025-08-20T03:47:57ZengMDPI AGNursing Reports2039-439X2039-44032025-05-0115515810.3390/nursrep15050158The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi StudyCarla Meyer-Massetti0Stefanie Lettieri-Amstutz1Daniela Rölli2Christoph R. Meier3Clinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, SwitzerlandClinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, SwitzerlandClinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, SwitzerlandClinical Pharmacy & Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland<b>Background:</b> Medication-related problems (MRPs) are common among home-care patients urgently needing improvement. Due to limited resources, patients with the greatest risk of MRPs should be prioritised for interventions. <b>Objectives:</b> We sought to develop a collaborative assessment tool for nurses and pharmacists to identify home-care patients at high risk of developing MRPs. <b>Methods:</b> Using Pubmed<sup>®</sup> for a first scoping literature review, we sought existing tools identifying patients at risk of MRPs or prioritising patients for clinical pharmacy services. Extracted items were prioritised in a first interprofessional Delphi round. Results from the first Delphi round were complemented by individual risk factors identified in a second scoping literature review and again submitted to the expert panel in a second Delphi round. Each item was rated for its relevance to identify home-care patients at risk of MRPs. The highest scoring factors were combined into an interprofessional assessment tool. <b>Results:</b> Literature review one yielded 19 risk tools and six lists containing potentially inappropriate medications. The 78 resulting risk factors were submitted to experts (five pharmacists, five physicians, five nurses) in Delphi round one. Since the identified tools did not fit the scope (interprofessional assessment in home care) entirely, the results of Delphi round one were complemented with individual risk factors identified in a second literature review, leading to 82 potential risk factors for Delphi round two. Experts decided on a 15-item tool for future pilot testing—the doMESTIC RISK tool. It incorporated diverse factors potentially influencing medication safety: demographic information, social context, diagnosis, specific medication and health care resources use. <b>Conclusions:</b> With expert feedback from a Delphi process, we developed a 15-item tool to help nurses and pharmacists jointly identify home-care patients at a high risk of MRPs. Validation of the doMESTIC RISK tool will be imperative to verify its value in clinical practice.https://www.mdpi.com/2039-4403/15/5/158home caremedication-related problemsmedication safetyrisk factorsrisk assessmentclinical pharmacy
spellingShingle Carla Meyer-Massetti
Stefanie Lettieri-Amstutz
Daniela Rölli
Christoph R. Meier
The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
Nursing Reports
home care
medication-related problems
medication safety
risk factors
risk assessment
clinical pharmacy
title The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
title_full The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
title_fullStr The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
title_full_unstemmed The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
title_short The doMESTIC RISK Tool: Prioritising Home-Care Patients for Clinical Pharmacy Services with the Help of a Delphi Study
title_sort domestic risk tool prioritising home care patients for clinical pharmacy services with the help of a delphi study
topic home care
medication-related problems
medication safety
risk factors
risk assessment
clinical pharmacy
url https://www.mdpi.com/2039-4403/15/5/158
work_keys_str_mv AT carlameyermassetti thedomesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT stefanielettieriamstutz thedomesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT danielarolli thedomesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT christophrmeier thedomesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT carlameyermassetti domesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT stefanielettieriamstutz domesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT danielarolli domesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy
AT christophrmeier domesticrisktoolprioritisinghomecarepatientsforclinicalpharmacyserviceswiththehelpofadelphistudy